|Articles|August 1, 2003
Supplements and Featured Publications
- Examining the Dyslipidemia Constellation
- Volume 9
- Issue 1 Dyslipid
NCEP ATP III guidelines incorporate global risk assessment
Author(s)Antionio M. Gotto, DPhil
Advertisement
Articles in this issue
over 22 years ago
Case reports illustrate consequences of ATP III in practiceover 22 years ago
Inflammatory markers are useful risk assessment toolsover 22 years ago
IVUS is redefining atherosclerotic diseaseNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
5 Things to Know About the Oral GLP-1 Era
4
Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention
5
